The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.40
Bid: 45.40
Ask: 45.70
Change: 0.60 (1.34%)
Spread: 0.30 (0.661%)
Open: 45.80
High: 45.80
Low: 45.40
Prev. Close: 44.80
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£13m Nottingham Office Disposal

11 Feb 2022 07:00

RNS Number : 3639B
Schroder Real Estate Inv Trst Ld
11 February 2022
 

For release 11 February 2022

 

Schroder Real Estate Investment Trust Limited

("SREIT"/ the "Company" / "Group")

 

£13M NOTTINGHAM OFFICE DISPOSAL ACHIEVED AT 39% PREMIUM TO VALUATION

 

Schroder Real Estate Investment Trust, the actively managed UK-focused REIT, announces that it has exchanged unconditional contracts to sell The Arc, a 44,602 sq ft office in Nottingham. The disposal price represents a 39% premium to the 31 December 2021 independent valuation of £9.35 million and reflects a net initial yield of 4.5%. Completion is scheduled on 28 February 2022.

 

Situated on the edge of Nottingham city centre, the Company acquired The Arc in August 2018. The asset produces a net rent of £622,210 per annum with a WAULT of 1.7 years. Based on the disposal price, the asset has generated an ungeared total return of 12.1% per annum since acquisition, compared with the All Property MSCI Benchmark for the same period of 5.4% per annum, and MSCI All Offices for the same period of 3.5% per annum.

 

SREIT will announce its unaudited Net Asset Value as at 31 December 2021 during the week commencing 28 February 2022.

 

Nick Montgomery, Fund Manager of SREIT, commented:

"This sale demonstrates our ability to leverage the expertise of sector specialists to generate strong returns for shareholders. Having completed our business plan for this well located asset, we see attractive opportunities to redeploy the capital which, alongside the Company's pipeline of ongoing asset management activity, should support SREIT's ambition to deliver a progressive and sustainable dividend."

 

-ENDS-

 

For further information:

 

Schroder Real Estate Investment Management Limited:Nick Montgomery / Bradley Biggins / Matthew Riley

020 7658 6000

FTI Consulting:

Dido Laurimore / Richard Gotla / Ollie Parsons

020 3727 1000

 

About Schroder Real Estate Investment Trust

Schroder Real Estate Investment Trust aims to provide shareholders with an attractive level of income together with the potential for income and capital growth as a result of its investments in, and active management of, a diversified portfolio of UK commercial real estate.

 

The investment policy of the Company is to own a diversified portfolio of UK real estate underpinned by good fundamental characteristics. The Group invests principally in the industrial, office and retail sectors and will also consider other sectors including mixed-use, residential, hotels, healthcare and leisure.

 

Leveraging the specialist capabilities of Schroders' multi-strategy, 95 strong across the UK team, SREIT employs a hospitality-driven approach to improve the operational performance of its assets, underpinned by a fully integrated ESG strategy, in order to deliver superior shareholder returns.

 

SREIT is currently paying an annualised dividend of 2.903 pence per share.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKKBNKBKBDBD
Date   Source Headline
29th Apr 20247:00 amRNSNotice of Results
13th Mar 20244:44 pmRNSHolding(s) in Company
8th Mar 20245:01 pmRNSHolding(s) in Company
6th Mar 20245:46 pmRNSHolding(s) in Company
6th Mar 20245:42 pmRNSHolding(s) in Company
29th Feb 20242:13 pmRNSInvestor Presentation
27th Feb 20247:00 amRNSNAV and Dividend for Quarter to 31 December 2023
26th Jan 20245:02 pmRNSQuotedData's Weekly News & Interview
26th Jan 20244:23 pmRNSQuotedData's Weekly News & Interview
15th Dec 20231:03 pmRNSResult of EGM
11th Dec 202312:13 pmRNSHolding(s) in Company
21st Nov 20238:35 amRNSWebinar details
21st Nov 20237:01 amRNSDividend Announcement for the Quarter to 30 Sep 23
21st Nov 20237:00 amRNSPublication of circular and notice of EGM
21st Nov 20237:00 amRNSInterim Results for the period ended 30 Sept 2023
1st Nov 20237:00 amRNSNon-Executive Director Change
18th Oct 20234:08 pmRNSInvestor Presentation
27th Sep 20234:54 pmRNSResult of AGM
26th Sep 20234:47 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSNotice of Results
8th Sep 202311:21 amRNSHolding(s) in Company
27th Jul 20232:43 pmRNSAnnual Report for year ended 31 March 2023
27th Jul 20232:11 pmRNSInvestor Presentation
27th Jul 20237:00 amRNSNAV and Dividend for the Quarter to 30 June 2023
8th Jun 20236:26 pmRNSDividend PID Status
8th Jun 202311:29 amRNSHolding(s) in Company
8th Jun 20237:01 amRNSDividend Declaration
8th Jun 20237:00 amRNSFull Year Results for the year ended 31 March 2023
2nd Jun 202311:18 amRNSInvestor Presentation
2nd May 20239:00 amRNSNotice of Full Year Results
20th Apr 202310:12 amRNSDirector Declaration
10th Mar 20232:12 pmRNSDirector/PDMR Shareholding
1st Mar 20234:34 pmRNSHolding(s) in Company
3rd Feb 20234:13 pmRNSInvestor Presentation
3rd Feb 20237:00 amRNSNAV and Dividend for the quarter to 30 Dec 2022
12th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
1st Dec 20224:41 pmRNSHolding(s) in Company
16th Nov 20227:01 amRNSDividend Declaration
16th Nov 20227:01 amRNSDirectorate Change
16th Nov 20227:00 amRNSInterim results for the period ended 30 September
19th Oct 20227:00 amRNSInvestor Presentation
12th Oct 20227:00 amRNSNotice of Half Year Results
30th Sep 20224:53 pmRNSTotal Voting Rights
21st Sep 20224:10 pmRNSResult of AGM
15th Sep 20225:34 pmRNSTransaction in Own Shares
14th Sep 20225:18 pmRNSTransaction in Own Shares
13th Sep 20225:21 pmRNSTransaction in Own Shares
12th Sep 20225:33 pmRNSTransaction in Own Shares
9th Sep 20225:33 pmRNSTransaction in Own Shares
8th Sep 20225:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.